1-1054900-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_198576.4(AGRN):​c.6057C>T​(p.Asp2019Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.682 in 1,549,936 control chromosomes in the GnomAD database, including 367,096 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.59 ( 28846 hom., cov: 34)
Exomes 𝑓: 0.69 ( 338250 hom. )

Consequence

AGRN
NM_198576.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.712

Publications

18 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 1-1054900-C-T is Benign according to our data. Variant chr1-1054900-C-T is described in ClinVar as Benign. ClinVar VariationId is 128319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.712 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.791 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.6057C>T p.Asp2019Asp synonymous_variant Exon 36 of 36 ENST00000379370.7 NP_940978.2 O00468-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.6057C>T p.Asp2019Asp synonymous_variant Exon 36 of 36 1 NM_198576.4 ENSP00000368678.2 O00468-6

Frequencies

GnomAD3 genomes
AF:
0.591
AC:
89880
AN:
152000
Hom.:
28830
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.323
Gnomad AMI
AF:
0.673
Gnomad AMR
AF:
0.720
Gnomad ASJ
AF:
0.662
Gnomad EAS
AF:
0.812
Gnomad SAS
AF:
0.607
Gnomad FIN
AF:
0.634
Gnomad MID
AF:
0.639
Gnomad NFE
AF:
0.696
Gnomad OTH
AF:
0.600
GnomAD2 exomes
AF:
0.676
AC:
104123
AN:
153932
AF XY:
0.675
show subpopulations
Gnomad AFR exome
AF:
0.311
Gnomad AMR exome
AF:
0.772
Gnomad ASJ exome
AF:
0.658
Gnomad EAS exome
AF:
0.814
Gnomad FIN exome
AF:
0.641
Gnomad NFE exome
AF:
0.698
Gnomad OTH exome
AF:
0.676
GnomAD4 exome
AF:
0.692
AC:
967055
AN:
1397818
Hom.:
338250
Cov.:
88
AF XY:
0.690
AC XY:
475706
AN XY:
689810
show subpopulations
African (AFR)
AF:
0.308
AC:
9780
AN:
31770
American (AMR)
AF:
0.762
AC:
27531
AN:
36128
Ashkenazi Jewish (ASJ)
AF:
0.658
AC:
16565
AN:
25172
East Asian (EAS)
AF:
0.830
AC:
29822
AN:
35928
South Asian (SAS)
AF:
0.612
AC:
48541
AN:
79286
European-Finnish (FIN)
AF:
0.645
AC:
30503
AN:
47274
Middle Eastern (MID)
AF:
0.661
AC:
2851
AN:
4316
European-Non Finnish (NFE)
AF:
0.706
AC:
762723
AN:
1080050
Other (OTH)
AF:
0.669
AC:
38739
AN:
57894
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
20262
40524
60787
81049
101311
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19370
38740
58110
77480
96850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.591
AC:
89927
AN:
152118
Hom.:
28846
Cov.:
34
AF XY:
0.592
AC XY:
44024
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.323
AC:
13380
AN:
41474
American (AMR)
AF:
0.720
AC:
11016
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.662
AC:
2299
AN:
3472
East Asian (EAS)
AF:
0.812
AC:
4207
AN:
5182
South Asian (SAS)
AF:
0.607
AC:
2928
AN:
4820
European-Finnish (FIN)
AF:
0.634
AC:
6727
AN:
10606
Middle Eastern (MID)
AF:
0.646
AC:
190
AN:
294
European-Non Finnish (NFE)
AF:
0.696
AC:
47297
AN:
67952
Other (OTH)
AF:
0.603
AC:
1273
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1719
3438
5157
6876
8595
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
742
1484
2226
2968
3710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.658
Hom.:
12328
Bravo
AF:
0.588
Asia WGS
AF:
0.693
AC:
2411
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 19, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Congenital myasthenic syndrome 8 Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
0.36
DANN
Benign
0.77
PhyloP100
-0.71
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.5
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4275402; hg19: chr1-990280; COSMIC: COSV65070964; COSMIC: COSV65070964; API